You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 3, March 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Confirmation of Organophosphate Poisoning by Serial Cholinesterase Analyses

Molly J. Coye, MD, MPH; Paul G. Barnett; John E. Midtling, MD, MS; Antonio R. Velasco, MD; Pablo Romero, MD; Charlie L. Clements, MD, MPH; Theodore G. Rose, MD

Arch Intern Med. 1987;147(3):438-442.


Abstract

• Three groups of agricultural workers with a history of exposure to organophosphate pesticides were followed up to evaluate the utility of sequential postexposure cholinesterase analyses to confirm organophosphate intoxication in the absence of baseline cholinesterase values. Three or more cholinergic symptoms were reported by 50 of the 72 patients. Initial plasma and red blood cell cholinesterase values of 45 of the workers were above the lower limit of the laboratory normal range. Follow-up examinations, including cholinesterase analyses, were conducted on 57 patients. When final postexposure cholinesterase determinations were taken as estimates of individual normal baseline values, the plasma and red blood cell activity of the three groups was shown to have been inhibited. The data support the use of sequential postexposure plasma cholinesterase analyses to confirm the diagnosis of organophosphate-induced illness in the absence of baseline values.

(Arch Intern Med 1987;147:438-442)



Author Affiliations

From the Division of Family and Community Medicine (Drs Midtling, Velasco, Romero, and Clements) and the Department of Internal Medicine (Drs Coye and Rose), University of California, San Francisco; and the Natividad Medical Center, Salinas, Calif (Mr Barnett and Drs Midtling, Velasco, Romero, Clements, and Rose). Dr Rose is now with Highland General Hospital, Oakland, Calif.


Footnotes

Accepted for publication May 16, 1986.

Reprint requests to Natividad Medical Center, PO Box 81611, Salinas, CA 93912 (Dr Midtling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acute cholinergic syndrome following ingestion of contaminated herbal extract
Hsieh et al.
Emerg. Med. J. 2008;25:781-782.
ABSTRACT | FULL TEXT  

Grand Mal Seizure in a Child 30 Minutes After Cyclogyl (Cyclopentolate Hydrochloride) and 10% Neo-Synephrine (Phenylephrine Hydrochloride) Eye Drops Were Instilled
Demayo and Reidenberg
Pediatrics 2004;113:e499-e500.
ABSTRACT | FULL TEXT  

Adult Toxicology in Critical Care: Part II: Specific Poisonings
Mokhlesi et al.
Chest 2003;123:897-922.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.